Western Digital Corp vs Zimmer Biomet Holdings Inc — how do they compare? Western Digital Corp trades at $397.28 (market cap $147.23B), while Zimmer Biomet Holdings Inc trades at $89.14 (market cap $16.95B). The key difference: Western Digital Corp is far larger — about 8.7× Zimmer Biomet Holdings Inc's market cap, and Zimmer Biomet Holdings Inc pays the higher dividend (1.08%). Which is the better fit depends on your goals — on Pluang, investors hold Western Digital Corp for 37 Days and Zimmer Biomet Holdings Inc for 89 Days on average.
| WDC | ZBH | |
|---|---|---|
Market Cap | $147.23B | $16.95B |
Volume | 9,341,468 | 2,505,240 |
Sector | Technology | Health |
52-Week High | $746.23 | $103.98 |
52-Week Low | $113.13 | $79.58 |
Typical Hold Time | 37 Days | 89 Days |
Enterprise Value | $146.70B | $24.02B |
Dividend Yield | 0.15% | 1.08% |
Signals from Pluang's Aura AI — not financial advice
Western Digital (WDC) trades at $393.31, down 2.94% amid concerns about increased competition from Toshiba's planned HDD production expansion. The stock shows strong fundamentals with consistent earnings beats (Q4 2025-Q2 2026) and impressive profitability metrics including 71.97% net income margin and 131.02% ROE. Technical indicators signal bearish momentum with the price below key resistance levels, while analyst consensus remains overwhelmingly bullish with a $647.58 price target representing 65% upside potential.
WDC presents a compelling investment case with robust AI-driven storage demand and strong financial performance, though near-term headwinds from competitive pressures and technical weakness warrant caution. The company's dominant market position and margin expansion potential support long-term growth, but investors should monitor Toshiba's competitive moves and quarterly execution against elevated expectations.
Zimmer Biomet (ZBH) trades at $88.91, up 0.47% today, with a bearish technical signal from moving averages. The company reported Q2 2026 EPS of $2.07, beating estimates, and raised its 2026 outlook. Revenue growth remains steady, with 2025 revenue at $8.23B, though net income margin declined to 8.56%. The stock is supported by a quarterly dividend of $0.24 and a consensus price target of $103.11, suggesting potential upside.
The outlook is mixed: strong fundamentals and analyst optimism contrast with technical weakness. Investment opportunities include consistent earnings beats and dividend income, but risks involve rising debt levels and competitive pressures in the medical technology sector. The stock's current valuation at a P/E of 21.57 appears reasonable if growth continues.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Western Digital is a vertically integrated supplier of data storage solutions, spanning both hard disk drives and solid-state drives. In the HDD market it forms a practical duopoly with Seagate, and it is the largest global producer of NAND flash chips for SSDs in a joint venture with competitor Kioxia.
Read more on WDC →Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →